Sponsor Pipeline

Dianthus Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT06537999
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy		 Enrollment closed, study ongoing
2026-08-11 NCT06537999
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy		 Enrollment increased: 36 -> 46 participants
2026-08-11 NCT06537999
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy		 date change Primary completion pushed: 2026-06-30 -> 2026-12
Active Trials by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07647510 A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis… Myasthenia Gravis, Generalized Recruiting
NCT06858579 A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic… Chronic Inflammatory Demyelinating Polyneuropathy Recruiting
Phase 2
NCT06282159 A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) Myasthenia Gravis, Generalized Active, Not Recruiting
NCT06537999 A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy Multifocal Motor Neuropathy Active, Not Recruiting
Disease Areas
Myasthenia Gravis (2)
Get alerts when Dianthus Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free